Výsledky léčby hypertenze v České republice v letech 1972-2022
- 1 Interní klinika FNKV a 3. LF UK, Praha
- 2 Interní klinika FN Motol a 2. LF UK, Praha
- 3 Státní zdravotní ústav, Praha
- 4 PřF UK, Praha
Published: September 4, 2024 Show citation
References
- Taniwall A, Broz J, Lustigova M, et al. Effectiveness of treatment of arterial hypertension in Central Europe from 1972 to 2022. Bratisl Lek Listy. 2024;125(5):322-330. doi: 10.4149/BLL_2024_48.
Go to original source...
Go to PubMed...
- Widimský J. 50 let historie léčby hypertenze. Triton, 2001:62-84.
- Cífková R, Škodová Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Čas Lék Čes. 2004;143:219-225.
- Cífková R, Bruthans J, Wohlfahrt P, et al. The prevalence of major cardiovascular risk factors in the Czech population in 2015-2018. The Czech post-MONICA study. Cor Vasa. 2020;62(1):6-16. doi: 10.33678/cor.2020.010.
Go to original source...
- Cífková R, Bruthans J, Strilchuk L, et al. Longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in the Czech population. Are there any sex differences? Front Cardiovasc Med. 2022 Nov 10;9:1033606. doi: 10.3389/fcvm.2022.1033606.
Go to original source...
Go to PubMed...
- Jozífová M, Cífková R, Škodová Z, et al. A comparison of hypertension control and the risk profile of hypertensives in the general population and in a specialist centre. Cor Vasa. 2003;44(11):533-41.
- Souček M, Widimský J, Žižka J, et al. Treatment of hypertension in an internist's office. Interní Medicína pro praxi. 2010;12(11):561-564.
- Vejtasová V, Lustigová M, Urbanová J, et al. Prevalence and management of arterial hypertension in the population aged 25-64 in the Czech Republic with a focus on diabetic patients. Epidemiol. Mikrobiol. Imunol. 2021;70(4):247-252.
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1.
Go to original source...
Go to PubMed...